while there was no quantitative alteration in t-lymphocytes , b-lymphocytes , natural killer ( nk ) cells , or cells bearing ia antigen , there was an increase in the percentage of cd-14 ( m5e2+ ) monocytes and dr+ monocytes by 2 weeks on therapy that persisted over the 8 weeks of monitoring .
C0026473
monocytes
C0108768
monocytes